StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)

Close on Nov 17, 2026Market cap $462.26MP/E –Yield –

Neurogene operating margin

Operating margin is operating income as a percentage of revenue.

Neurogene's operating margin for the twelve months ending Dec 31, 2024 was -8930.3%. For fiscal 2024 it was -8930.3%, against -130.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-8930.3%−8799.8
FY2018Dec 31, 2018-130.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-2176.6%–
Q2 FY2018Jun 30, 201810.8%–

More Neurogene figures

See a number that looks wrong?